Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers
· manilatimes.net
Silexion to present SIL-204 data at leading Cancer Symposium designed to feature the latest science in the field of GI cancers
Silexion to present SIL-204 data at leading Cancer Symposium designed to feature the latest science in the field of GI cancers
New preclinical data demonstrate...